A recent study suggests that antiplatelet therapy, commonly used to prevent blood clots, may reduce the severity and complications of COVID-19. The research indicates that these medications could help lower the risk of severe outcomes in patients with the virus. Antiplatelet therapy works by preventing platelets from sticking together and forming clots, which can be a major concern in COVID-19 patients. This finding highlights the potential benefits of using antiplatelet drugs as part of the treatment for COVID-19 to improve patient outcomes. The study reinforces the importance of exploring different treatment options to combat the virus.
Source link
Antiplatelet Therapy may Reduce COVID-19 Severity and Complications: Study
